MYC and B-cell non-Hodgkin lymphoma: High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements represent a quite recently defined entity of lymphoma with aggressive nature, high genomic complexity and poor prognosis [9].